Buys
Open market- Shares
- Avg price
- Total value
Rachel McMinn - Chief Executive Officer, Director at Neurogene Inc.
Issuer-level insider activity
- Role
- Chief Executive Officer, Director
- Issuer ticker
- NGNE on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Rachel McMinn in Neurogene Inc.
Sells
Open market- Shares
- -3,352
- Avg price
- $22.07
- Total value
- -$73,995
Net
Past year- Shares
- -3,352
- Share %
- -100%
- Total value
- -$73,995
Reported holdings for Rachel McMinn in Neurogene Inc.
Form 4 holding
Chief Executive Officer, Director
Neurogene Inc.
- Security class
- Common Stock
- Shares / value
- 1,344,307
- Estimated value
- $29,675,442
- Report date
- 26 Mar 2026
- Price
- $22.07
- Ownership
- Direct
Form 4 holding
Chief Executive Officer, Director
Neurogene Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 155,100
- Estimated value
- Report date
- 20 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Executive Officer, Director
Neurogene Inc.
- Security class
- Employee Stock Option (Right to buy)
- Shares / value
- 143,500
- Estimated value
- Report date
- 26 Mar 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Rachel McMinn in Neurogene Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.